Ginkgo (DNA) to Report Q2 Earnings: What's in the Cards? [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
Ginkgo's earnings met expectations in each of the trailing four quarters. Let's see how things have shaped up for the quarter to be reported. Ginkgo's revenues comprise sales from its two business segments — Biosecurity and Cell Engineering. Total revenues are likely to have declined in the to-be-reported quarter, owing to the expected ramp-down of the company's K-12 COVID testing services. In the last reported quarter, Cell Engineering services revenues decreased owing to a decline in revenues from early-stage customers. It remains to be seen whether the same trend continued in the second quarter. Shares of Ginkgo have plunged 80.1% so far this year compared with the industry's decline of 1.9%. Image Source: Zacks Investment Research Biosecurity business revenues have been declining since the K-12 COVID testing business ended. This segment has been witnessing a transition toward emerging product lines that are more recurring. The company continues to build both domesti
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors? [Yahoo! Finance]Yahoo! Finance
- Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement [Yahoo! Finance]Yahoo! Finance
- Ginkgo Regains Compliance with NYSE Minimum Bid Price RequirementPR Newswire
- Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNAGlobeNewswire
- 2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 8/8/24 - Miss
DNA
Sec Filings
- 9/6/24 - Form 144
- 9/5/24 - Form 144
- 9/4/24 - Form 8-K
- DNA's page on the SEC website